APA (7th ed.) Citation

M, M., DS, C., J, A., AM, M., S, P., O, S., . . . JJ, O. (2025). Deferral of systemic therapy in patients with oligorecurrent prostate cancer treated with metastasis-directed radiotherapy. Annals of translational medicine, 13(3), 29. https://doi.org/10.21037/atm-24-187

Chicago Style (17th ed.) Citation

M, Muniz, et al. "Deferral of Systemic Therapy in Patients with Oligorecurrent Prostate Cancer Treated with Metastasis-directed Radiotherapy." Annals of Translational Medicine 13, no. 3 (2025): 29. https://doi.org/10.21037/atm-24-187.

MLA (9th ed.) Citation

M, Muniz, et al. "Deferral of Systemic Therapy in Patients with Oligorecurrent Prostate Cancer Treated with Metastasis-directed Radiotherapy." Annals of Translational Medicine, vol. 13, no. 3, 2025, p. 29, https://doi.org/10.21037/atm-24-187.